The ‘Magnificent Seven’ stocks are actually undervalued vs. the rest of the market, JPMorgan, $JPM, has said

The ‘Magnificent Seven’ stocks are actually undervalued vs. the rest of the market, JPMorgan, $JPM, has said per MW.


In their analysis, JPMorgan's analysts pointed out that while the top tech companies, known as the Magnificent Seven, are currently trading at high absolute prices, they are actually trading at lower-than-average prices compared to the past five years. This is in contrast to the European cyclical sectors, which are experiencing stretched valuations.

The analysts, led by Mislav Matejka, highlighted that despite concerns about overvaluation and the potential end of the tech rally driven by artificial intelligence (AI), the Magnificent Seven - Alphabet (GOOGL), Amazon (AMZN), Apple (AAPL), Meta Platforms (META), Microsoft (MSFT), Nvidia (NVDA), and Tesla (TSLA) - are trading below median levels for the past five years based on a 12-month forward profit-to-earnings ratio.

In contrast, European cyclical stocks are trading at higher-than-average prices compared to defensives based on a 12-month forward profit-to-earnings ratio since 1995.

According to JPMorgan's analysts, there could be further concentration in stock markets, which would benefit the Magnificent Seven, currently representing 28% of the S&P 500's market capitalization.

The analysts highlighted the strong earnings performance of the Magnificent Seven in 2023, with these tech giants achieving a net income growth of 27% compared to the -4% net income growth of the rest of the S&P 500.

They also noted a similar trend in European markets, where the 'Granolas' (Great New Leaders) account for a quarter of the Stoxx 600 market capitalization, indicating increasing market concentration in Europe as well.

Unusual Whales does not confirm the information's truthfulness or accuracy of the associated references, data, and cannot verify any of the information. Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Options, investing, trading is risky, and losses are more expected than profits. Please do own research before investing. Please only subscribe after reading our full terms and understanding options and the market, and the inherent risks of trading. It is highly recommended not to trade on this, or any, information from Unusual Whales. Markets are risky, and you will likely lose some or all of your capital. Please check our terms for full details.
Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Certain investment planning tools available on Unusual Whales may provide general investment education based on your input. You are solely responsible for determining whether any investment, investment strategy, security or related transaction is appropriate for you based on your personal investment objectives, financial circumstances and risk tolerance. You should consult your legal or tax professional regarding your specific situation. See terms for more information.